Side-by-side comparison
ABBV vs RHHBY — Side-by-side comparison
ABBV screens cheaper on EV/FCF, ABBV has the higher ROIC, ABBV has grown revenue faster over five years, and ABBV has the cleaner balance sheet by net debt / EBITDA.
ABBV
AbbVie Inc.
Price
$215.70
Market cap
$346.8B
Day %
N/A
RHHBY
Roche Holding AG ADR
Price
$53.38
Market cap
$265.2B
Day %
N/A
Peer Comparison
Target stock against 1 market-cap comparable peer.
Heat map: red worst to green best
ABBV implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
22.8x
FCF yield
5.1%
5Y rev CAGR
6.0%
RHHBY implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for ABBV.
Grade C
51
/ 100
Quality Scorecard
Build-time composite score for RHHBY.
Grade F
0
/ 100